NEW · Pharmaceuticals
BMY
Bristol-Myers Squibb Co · $134.92B
67.61
+2.36%
Price
62 sessions shownTechnicals
from daily closesRSI · 14 day
62.1
Avg true range · 14d
2.72%
Volatility · 20d annualised
23.6%
Trend · 20d vs 50d
Up
vs 20-day average
5.16%
vs 50-day average
12.58%
vs 200-day average
—
200-day average
—
Internals
where it sits, and how hard it is being traded52-week low
42.52
52-week high
68.10
Volume vs its 20-day avg
0.86×
Beta vs the market
0.17
Sitting 98% of the way up its 52-week range (42.52 → 68.10)
Swings
prices it actually turned at — highest or lowest of the surrounding 11 sessionsTurned down · Jun 5
57.82
Turned down · Jun 30
58.88
Turned down · Aug 3
68.10
Turned up · Jun 18
53.44
Turned up · Jul 14
56.78
Turned up · Aug 12
63.00
Fundamentals
P/E
14.21
Fwd P/E
—
P/S
2.68
P/B
5.94
EV/EBITDA
11.03
ROE
46.8%
ROA
10.3%
Gross margin
71.7%
Net margin
—
Debt / equity
2.44
Rev growth
3.1%
EPS growth
5.5%
Every figure here is measured from live market data as of Aug 19, 08:08 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.